<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505256</url>
  </required_header>
  <id_info>
    <org_study_id>BEST P-01</org_study_id>
    <nct_id>NCT02505256</nct_id>
  </id_info>
  <brief_title>Study Into Treatment of Hyperplasia of Mammary Glands</brief_title>
  <official_title>Study Into Treatment of Hyperplasia of Mammary Glands</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperplasia of Mammary Glands is a complex disease, and there is no consensus or guideline
      for the treatment of this disease. This study was launched to investigate into the problem
      that which patients should be diagnosed as hyperplasia of mammary glands and which patients
      should be treated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Females who meet the inclusion criteria will receive breast ultrasonography, mammography and
      pathological examinations by core needle biopsy. All participants will receive a follow-up at
      an 6-month interval for 2 years. During the follow-up period, whether the symptoms relieve
      will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical manifestations as an substitutive indicator for pathological diagnosis of hyperplasia of mammary glands</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical manifestations as an surgical indications for hyperplasia of mammary glands</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Hyperplasia</condition>
  <arm_group>
    <arm_group_label>case group</arm_group_label>
    <description>cases who presented as breast pain or breast lumps, and no intervention will be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>case group</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      breast tissues
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Females who reported breast pain of breast lumps.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reported breast pain or breast lumps.

          -  Willing to be kept follow-up.

          -  Functions below are maintained in major organs: liver, renal and heart.

          -  Written informed consent will be obtained for patients for entering this study.

        Exclusion Criteria:

          -  Typical breast cancer or fibroadenoma.

          -  Classification by breast ultrasonography of mammography is beyond Breast Imaging -
             Reporting And Data System (BI-RADS) 4.

          -  Oral contraceptive or hormone replacement therapy.

          -  History of breast cancer or other malignancies.

          -  History of pituitary gland disease.

          -  Potentially pregnant, pregnant, or breast-feeding.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gang Z Yu, PhDï¼ŒMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gang Z Yu, PhD, MD</last_name>
    <phone>+13864182636</phone>
    <email>yzg@medmail.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>the Second Hospital of Shandong Universtity</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gang Z Yu, Dr; PhD</last_name>
      <phone>+86 0531-85875048</phone>
      <email>yzg@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Gang Z Yu, Dr; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>July 21, 2015</last_update_submitted>
  <last_update_submitted_qc>July 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yu-Zhi Gang</investigator_full_name>
    <investigator_title>Chief of Department of Breast Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

